EGFR and hepatocellular carcinoma: However, YTHDF2 may contribute to the cancer stem cell phenotype through the YTHDF2/OCT4 pathway, and at the same time, it could act as an HCC suppressor, influencing the ERK/MAPK pathway and initiating EGFR mRNA decay [69].